November 2025
1. KEAM SJ
   Gepotidacin: First Approval.
   Drugs. 2025;85:1479-1485.
   

   >> Share

   
   March 2025
2. FUNG S, Shirley M
   Rezafungin: A Review in Invasive Candidiasis.
   Drugs. 2025;85:415-423.
   

   >> Share

   
   
3. HEIMANN D, Kohnhauser D, Kohnhauser AJ, Bronstrup M, et al
   Antibacterials with Novel Chemical Scaffolds in Clinical Development.
   Drugs. 2025;85:293-323.
   

   >> Share

   
   January 2025
4. IOVLEVA A, Fowler VG Jr, Doi Y
   Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections.
   Drugs. 2025;85:21-40.
   

   >> Share

   
   December 2024
5. RAUCH A, Kohler N, Brehm TT, Zielinski N, et al
   Long-Term Self-Administered Outpatient Parenteral Antimicrobial Therapy in the Treatment of Tuberculosis.
   Drugs. 2024 Dec 29. doi: 10.1007/s40265-024-02122.
   

   >> Share

   
   
6. CHIHOTA V, Gombe M, Gupta A, Salazar-Austin N, et al
   Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review.
   Drugs. 2024 Dec 28. doi: 10.1007/s40265-024-02131.
   

   >> Share

   
   
7. SCHELLONG P, Joean O, Pletz MW, Hagel S, et al
   Treatment of Complicated Gram-Positive Bacteremia and Infective Endocarditis.
   Drugs. 2024 Dec 25. doi: 10.1007/s40265-024-02135.
   

   >> Share

   
   
8. HIDALGO-TENORIO C, Bou G, Oliver A, Rodriguez-Aguirregabiria M, et al
   The Challenge of Treating Infections Caused by Metallo-beta-Lactamase-Producing Gram-Negative Bacteria: A Narrative Review.
   Drugs. 2024;84:1519-1539.
   

   >> Share

   
   June 2024
9. KEAM SJ
   Cefepime/Enmetazobactam: First Approval.
   Drugs. 2024;84:737-744.
   

   >> Share

   
   March 2024
10. BLAIR HA
    SER-109 (VOWST()): A Review in the Prevention of Recurrent Clostridioides difficile Infection.
    Drugs. 2024;84:329-336.
    

    >> Share

    
    
11. SHIRLEY M
    Vonoprazan: A Review in Helicobacter pylori Infection.
    Drugs. 2024;84:319-327.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share